SPIA
CPRX

Steward Partners Investment Advisory’s Catalyst Pharmaceutical CPRX Stock Holding History

Steward Partners Investment Advisory’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.1K Hold
734
– – ﹤0.01% 3359
2026
Q1 		$18.2K Hold
734
– – ﹤0.01% 3275
2025
Q4 		$17.1K Hold
734
– – ﹤0.01% 3198
2025
Q3 		$14.5K Hold
734
– – ﹤0.01% 3237
2025
Q2 		$15.9K Sell
734
-43,021
-98% -$1.02M ﹤0.01% 3008
2025
Q1 		$1.06M Buy
43,755
+42,482
+3,337% +$957K 0.01% 895
2024
Q4 		$26.6K Buy
+1,273
New +$27.3K ﹤0.01% 2644
2024
Q1 		– Sell
-600
Closed -$10.1K – 3592
2023
Q4 		$10.1K Hold
600
– – ﹤0.01% 2709
2023
Q3 		$7.01K Buy
600
+100
+20% +$1.34K ﹤0.01% 2705
2023
Q2 		$6.72K Buy
500
+300
+150% +$4.32K ﹤0.01% 2695
2023
Q1 		$3.32K Buy
200
+120
+150% +$1.98K ﹤0.01% 2911
2022
Q4 		$1.49K Hold
80
– – ﹤0.01% 3077
2022
Q3 		$1K Buy
+80
New +$948 ﹤0.01% 3109
2021
Q2 		– Sell
-2,600
Closed -$12K – 7147
2021
Q1 		$12K Buy
+2,600
New +$10.3K ﹤0.01% 2704
2020
Q1 		– Sell
-2,500
Closed -$9K – 2521
2019
Q4 		$9K Sell
2,500
-2,000
-44% -$9.35K ﹤0.01% 2042
2019
Q3 		$23K Buy
4,500
+2,000
+80% +$10.7K ﹤0.01% 1675
2019
Q2 		$9K Buy
+2,500
New +$10.8K ﹤0.01% 2012
2018
Q4 		– Sell
-2,500
Closed -$9K – 1020
2018
Q3 		$9K Hold
2,500
– – ﹤0.01% 1910
2018
Q2 		$8K Buy
+2,500
New +$7.58K ﹤0.01% 1807

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Steward Partners Investment Advisory's CPRX Position: Q2 2026 in Review

Steward Partners Investment Advisory held its Catalyst Pharmaceutical (CPRX) position steady in Q2 2026 at 734 shares worth $23.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3359.

Steward Partners Investment Advisory first reported a position in CPRX in Q2 2018 and has held it in 19 quarters since. The position peaked at $1.06M in Q1 2025. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Steward Partners Investment Advisory held 734 shares of Catalyst Pharmaceutical worth $23.1K as of Q2 2026.
  • Steward Partners Investment Advisory left its Catalyst Pharmaceutical share count unchanged in Q2 2026.
  • Catalyst Pharmaceutical made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #3359 holding.
  • Steward Partners Investment Advisory first reported a position in Catalyst Pharmaceutical in Q2 2018 and has held it in 19 quarters since.
  • Steward Partners Investment Advisory's Catalyst Pharmaceutical position peaked at $1.06M in Q1 2025.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.